Evidence map›Paper›PMID 38910189›Full record

ArticleChinese journal of integrative medicine2025

Effectiveness of Lianhua Qingwen Granule and Jingyin Gubiao Prescription in Omicron BA.2 Infection and Hospitalization: A Real-World Study of 56,244 Cases in Shanghai, China.

Yu-Jie Zhang, Guo-Jian Liu, Han Zhang, Chen Liu, Zhi-Qiang Chen, Ji-Shu Xian, Da-Li Song, Zhi Liu, Xue Yang, Ju Wang and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Chinese journal of integrative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yu-Jie ZhangDepartment of Basic Medicine, Army Medical University, Chongqing, 400038, China.
Guo-Jian LiuDepartment of Basic Medicine, Army Medical University, Chongqing, 400038, China.
Han ZhangDepartment of Basic Medicine, Army Medical University, Chongqing, 400038, China.
Chen LiuDepartment of Radiology, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Zhi-Qiang ChenDepartment of Pediatrics, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Ji-Shu XianDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Da-Li SongDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Zhi LiuDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Xue YangDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Ju WangDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Zhe ZhangState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, 519000, China.
Lu-Ying ZhangDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Hua FengDepartment of Neurosurgery, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China.
Yan-Qi ZhangDepartment of Health Statistics, College of Military Preventive Medicine, Army Medical University, Chongqing, 400038, China. zyqtmmu@163.com.
Liang TanDepartment of Critical Care Medicine, The First Affiliated Hospital of the Army Medical University, Chongqing, 400038, China. tracy200712@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the effectiveness of Chinese medicine (CM) Lianhua Qingwen Granule (LHQW) and Jingyin Gubiao Prescription (JYGB) in asymptomatic or mild patients with Omicron infection in the shelter hospital.

methodsThis single-center retrospective cohort study was conducted in the largest shelter hospital in Shanghai, China, from April 10, 2022 to May 30, 2022. A total of 56,244 asymptomatic and mild Omicron cases were included and divided into 4 groups, i.e., non-administration group (23,702 cases), LHQW group (11,576 cases), JYGB group (12,112 cases), and dual combination of LHQW and JYGB group (8,854 cases). The length of stay (LOS) in the hospital was used to assess the effectiveness of LHQW and JYGB treatment on Omicron infection.

resultsPatients aged 41-60 years, with nadir threshold cycle (C

conclusionsPatients with a nadir C

Indexed as

COVID-19COVID-19 Drug TreatmentDrugs, Chinese HerbalHospitalizationAdultAgedChinaFemaleHumansLength of StayMaleMiddle AgedRetrospective StudiesSARS-CoV-2Treatment OutcomeYoung AdultDrugs, Chinese HerballianhuaqingwenChinese medicineCOVID-19Jingyin Gubiao PrescriptionLianhua Qingwen GranuleOmicron

Identifiers

PMID38910189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.